lobbying_activities: 2185331

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2185331	a9b9622e-4b75-499f-8b7a-6ab06ebd5f34	Q3	W STRATEGIES, LLC	400605842	23ANDME, INC.	2018	third_quarter	MED	Issues related to regulation of Direct to Consumer (DTC) Genetic Testing and education and outreach regarding genetic testing and personalized medicine, including FDA regulation of DTC tests and privacy in consumer genetics. FDA draft guidance related to regulatory oversight of laboratory developed tests and the development of legislation related to oversight of LDTs.	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2018-10-16T11:55:12.757000-04:00